Elenco degli articoli con argomento «cancro»


28 lug 2023

Un modello di potenziamento dell'apprendimento per il supporto decisionale basato sull'IA nel cancro della pelle navigation-next-alternate

Paper dello studio pubblicato su Nature Medicine il 27 luglio 2023

06 mar 2023

Nicotinamide for Skin-Cancer Chemoprevention

Immunosuppressed organ-transplant recipients have an increased incidence of, and mortality from, skin cancer

20 feb 2023

Treatment of Severe Atopic Dermatitis with Dupilumab

Atopic dermatitis is a chronic inflammatory intensively pruritic skin disease.

30 gen 2023

Combined Use of Dermoscopy, Reflectance Confocal Microscopy

Combined Use of Dermoscopy, Reflectance Confocal Microscopy and Ex-vivo Gene Expression Profiling to Detect a Micro-melanoma Less Than 1 mm in Diameter.

24 ott 2022

Non-Melanoma Skin Cancer Clearance

Non-melanoma skin cancer (NMSC) treated with nonsurgical therapies can be monitored with noninvasive skin imaging.

28 set 2022

The role of HPV in keratinocyte skin cancer development

Keratinocyte skin cancers are the most frequent malignancy, accounting for approximately 30% of all cancers

27 lug 2022

New insights from non-invasive imaging

The incidence of non-melanoma skin cancer is on the rise and melanoma is among the most common cancers in the United States.

20 giu 2022

Sentinel lymph node biopsy in Merkel cell carcinoma

Sentinel lymph node biopsy in Merkel cell carcinoma: Rates and predictors of compliance with the National Comprehensive Cancer Network guidelines

08 giu 2022

Alopecia legata ai trattamenti antitumorali navigation-next-alternate

Questo opuscolo ha lo scopo di aiutarla a comprendere meglio l’alopecia e i cambiamenti dei capelli

04 apr 2022

Comparative Analysis of PRAME Expression

PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low levels in gonadal

21 feb 2022

Systemic Treatment of Cutaneous Adverse Events

As treatment with immune checkpoint inhibitors (CPIs) for cancer increases, so has the incidence of immune-related cutaneous adverse events (irCAEs).

04 feb 2022

Addressing Skin Cancer Prevention across the EU navigation-next-alternate

On #WorldCancerDay, we support @eadv’s #JointStatement on #skincancer prevention. Together with #dermatology and other HCPs, patients, trade unions & MEPs, we urge action on more measures needed in the context of Europe’s #BeatingCancerPlan.

24 gen 2022

The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma

Cutaneous squamous cell carcinomas (CSCC) account for about 20% of all keratinocyte carcinomas, which are the most common form of cancer.

06 dic 2021

Line-field confocal optical coherence tomography for the in vivo real-time diagnosis

The treatment of keratinocyte cancers (KC) strictly depends on their differentiation and invasiveness.

15 nov 2021

Efficacy of a tailored moisturizer for reducing chemotherapy-induced

Efficacy of a tailored moisturizer for reducing chemotherapy-induced skin dryness in breast cancer patients

05 ott 2021

Surgical excision margins for fibrohistiocytic tumors

Mohs micrographic surgery or wide local excision is the treatment of choice for fibrohistiocytic tumors with metastatic potential

03 giu 2021

Dark pigmented lesions

There is lack of studies on the diagnostic accuracy of dermoscopy and reflectance confocal microscopy (RCM) for dark pigmented lesions.

10 mar 2021

Impact of delay in follow-up due to COVID-19

The COVID-19 pandemic required the setting of a national lockdown in Italy from March 9, 2020, until May 18, 2020

13 gen 2021

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)

20 ott 2020

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?